2017
HDR Monotherapy in Prostate Cancer: Radiobiological Considerations When Determining Biologically Effective Dose in Clinical Trials
Tien C, Carlson D, Nath R, Chen Z. HDR Monotherapy in Prostate Cancer: Radiobiological Considerations When Determining Biologically Effective Dose in Clinical Trials. Brachytherapy 2017, 16: s31. DOI: 10.1016/j.brachy.2017.04.038.Peer-Reviewed Original Research
2016
Fixed Cylinder Diameter for High-Dose-Rate Intravaginal Brachytherapy in Endometrial Cancer: One Size Does Not Fit All
Stahl J, Kim J, Geneser S, Carlson D, Damast S. Fixed Cylinder Diameter for High-Dose-Rate Intravaginal Brachytherapy in Endometrial Cancer: One Size Does Not Fit All. Brachytherapy 2016, 15: s115-s116. DOI: 10.1016/j.brachy.2016.04.187.Peer-Reviewed Original Research
2013
Dose Escalation, Not “New Biology,” Can Account for the Efficacy of Stereotactic Body Radiation Therapy With Non-Small Cell Lung Cancer
Brown JM, Brenner DJ, Carlson DJ. Dose Escalation, Not “New Biology,” Can Account for the Efficacy of Stereotactic Body Radiation Therapy With Non-Small Cell Lung Cancer. International Journal Of Radiation Oncology • Biology • Physics 2013, 85: 1159-1160. PMID: 23517805, PMCID: PMC3608927, DOI: 10.1016/j.ijrobp.2012.11.003.Peer-Reviewed Original Research